Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1980 2
1981 2
1982 1
1983 1
1984 4
1985 4
1986 3
1987 5
1988 2
1989 4
1990 4
1991 2
1992 13
1993 8
1994 10
1995 10
1996 12
1997 14
1998 13
1999 30
2000 21
2001 21
2002 23
2003 47
2004 55
2005 82
2006 85
2007 112
2008 111
2009 107
2010 109
2011 125
2012 112
2013 149
2014 169
2015 184
2016 193
2017 192
2018 211
2019 205
2020 247
2021 268
2022 237
2023 245
2024 59

Text availability

Article attribute

Article type

Publication date

Search Results

2,997 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Age related macular degeneration 13"
Page 1
What did we learn in 35 years of research on nutrition and supplements for age-related macular degeneration: a systematic review.
Pameijer EM, Heus P, Damen JAA, Spijker R, Hooft L, Ringens PJ, Imhof SM, van Leeuwen R. Pameijer EM, et al. Acta Ophthalmol. 2022 Dec;100(8):e1541-e1552. doi: 10.1111/aos.15191. Epub 2022 Jun 13. Acta Ophthalmol. 2022. PMID: 35695158 Free PMC article. Review.
The aim of this paper is to summarize all available evidence from systematic reviews, randomized controlled trials (RCTs) and comparative nonrandomized studies (NRS) on the association between nutrition and antioxidant, vitamin, and mineral supplements and the development or prog …
The aim of this paper is to summarize all available evidence from systematic reviews, randomized controlled trials (RCTs) and comparative no …
A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.
Markowitz SN, Devenyi RG, Munk MR, Croissant CL, Tedford SE, Rückert R, Walker MG, Patino BE, Chen L, Nido M, Tedford CE. Markowitz SN, et al. Retina. 2020 Aug;40(8):1471-1482. doi: 10.1097/IAE.0000000000002632. Retina. 2020. PMID: 31404033 Free PMC article. Clinical Trial.

Approximately 50% of PBM-treated subjects showed improvement of 5 letters versus 13.6% in sham-treated subjects at M1. High responding subjects (5-letter improvement) in the PBM-treated group showed a gain of 8 letters after initial treatment (P < 0.01) and exhibited ea

…
Approximately 50% of PBM-treated subjects showed improvement of 5 letters versus 13.6% in sham-treated subjects at M1. High respondin …
LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System.
Boyer D, Hu A, Warrow D, Xavier S, Gonzalez V, Lad E, Rosen RB, Do D, Schneiderman T, Ho A, Munk MR, Jaffe G, Tedford SE, Croissant CL, Walker M, Rückert R, Tedford CE. Boyer D, et al. Retina. 2024 Mar 1;44(3):487-497. doi: 10.1097/IAE.0000000000003980. Retina. 2024. PMID: 37972955 Free PMC article. Clinical Trial.
PURPOSE: The LIGHTSITE III study evaluated multiwavelength photobiomodulation (PBM) therapy in nonexudative (dry) age-related macular degeneration (AMD) using the LumiThera Valeda Light Delivery System. ...Subjects were assessed for efficacy and safety …
PURPOSE: The LIGHTSITE III study evaluated multiwavelength photobiomodulation (PBM) therapy in nonexudative (dry) age-related …
Complement System and Potential Therapeutics in Age-Related Macular Degeneration.
Park YG, Park YS, Kim IB. Park YG, et al. Int J Mol Sci. 2021 Jun 25;22(13):6851. doi: 10.3390/ijms22136851. Int J Mol Sci. 2021. PMID: 34202223 Free PMC article. Review.
Age-related macular degeneration (AMD) is a complex multifactorial disease characterized in its late form by neovascularization (wet type) or geographic atrophy of the retinal pigment epithelium cell layer (dry type). ...
Age-related macular degeneration (AMD) is a complex multifactorial disease characterized in its late form by neo …
Age-Related Macular Degeneration and Mortality: A Systematic Review and Meta-Analysis.
McGuinness MB, Karahalios A, Finger RP, Guymer RH, Simpson JA. McGuinness MB, et al. Ophthalmic Epidemiol. 2017 Jun;24(3):141-152. doi: 10.1080/09286586.2016.1259422. Epub 2017 Jan 31. Ophthalmic Epidemiol. 2017. PMID: 28139151 Review.
PURPOSE: Age-related macular degeneration (AMD) is the leading cause of severe, irreversible vision loss in older adults. ...Reference lists from identified studies and four clinical trial registries were searched for additional studies. Participants w …
PURPOSE: Age-related macular degeneration (AMD) is the leading cause of severe, irreversible vision loss in olde …
A proteogenomic signature of age-related macular degeneration in blood.
Emilsson V, Gudmundsson EF, Jonmundsson T, Jonsson BG, Twarog M, Gudmundsdottir V, Li Z, Finkel N, Poor S, Liu X, Esterberg R, Zhang Y, Jose S, Huang CL, Liao SM, Loureiro J, Zhang Q, Grosskreutz CL, Nguyen AA, Huang Q, Leehy B, Pitts R, Aspelund T, Lamb JR, Jonasson F, Launer LJ, Cotch MF, Jennings LL, Gudnason V, Walshe TE. Emilsson V, et al. Nat Commun. 2022 Jun 13;13(1):3401. doi: 10.1038/s41467-022-31085-x. Nat Commun. 2022. PMID: 35697682 Free PMC article.
Age-related macular degeneration (AMD) is one of the most common causes of visual impairment in the elderly, with a complex and still poorly understood etiology. ...A two-sample Mendelian randomization study identifies several proteins that are causall …
Age-related macular degeneration (AMD) is one of the most common causes of visual impairment in the elderly, wit …
Molecular Genetic Mechanisms in Age-Related Macular Degeneration.
Shughoury A, Sevgi DD, Ciulla TA. Shughoury A, et al. Genes (Basel). 2022 Jul 12;13(7):1233. doi: 10.3390/genes13071233. Genes (Basel). 2022. PMID: 35886016 Free PMC article. Review.
Age-related macular degeneration (AMD) is among the leading causes of irreversible blindness worldwide. ...
Age-related macular degeneration (AMD) is among the leading causes of irreversible blindness worldwide. ...
Association between age-related macular degeneration and subjective cognitive complaints.
Zhu Z, Liao H, Wang W, Scheetz J, Zhang J, He M. Zhu Z, et al. Br J Ophthalmol. 2020 Sep;104(9):1228-1233. doi: 10.1136/bjophthalmol-2019-314853. Epub 2019 Dec 4. Br J Ophthalmol. 2020. PMID: 31801734
PURPOSE: To investigate the association between age-related macular degeneration (AMD) and subjective cognitive complaints (SCCs) in the USA. ...Retinal photography was graded into no AMD, early and late AMD based on the modification of the Wisconsin …
PURPOSE: To investigate the association between age-related macular degeneration (AMD) and subjective cognitive …
Review of Fibrosis in Neovascular Age-Related Macular Degeneration.
Cheong KX, Cheung CMG, Teo KYC. Cheong KX, et al. Am J Ophthalmol. 2023 Feb;246:192-222. doi: 10.1016/j.ajo.2022.09.008. Epub 2022 Sep 24. Am J Ophthalmol. 2023. PMID: 36162537 Review.
PURPOSE: To report the diagnosis and definitions, epidemiology, risk factors, and visual outcomes of fibrosis in neovascular age-related macular degeneration (nAMD). DESIGN: Systematic review and meta-analysis. ...The prevalence of fibrosis at baseline …
PURPOSE: To report the diagnosis and definitions, epidemiology, risk factors, and visual outcomes of fibrosis in neovascular age-r …
Apelin-13: A Promising Biomarker for Age-Related Macular Degeneration?
Vural E, Hazar L, Karakukçu C, Arslan ME, Sirem MR, Sirakaya E, Ozsaygılı C, Çiçek A. Vural E, et al. Ophthalmologica. 2021;244(2):102-109. doi: 10.1159/000513050. Epub 2020 Nov 16. Ophthalmologica. 2021. PMID: 33197910
PURPOSE: To investigate the value of serum apelin-13 levels in patients with age-related macular degeneration (AMD). ...Further studies demonstrating the relationship of the level of serum apelin-13 and AMD are needed....
PURPOSE: To investigate the value of serum apelin-13 levels in patients with age-related macular degeneration …
2,997 results